Therapeutic Asset Ratings
154 results matching 1 filter
133,990 assets · 8,802 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Nivolumab
Cervical Cancer
Fred Hutchinson Cancer Center
P2
CCC
(54)
PEGFILGRASTIM
Cervical Cancer
University of California, Irvine
P2
CCC
(54)
e7 tcr-t cells
Cervical Cancer
Christian Hinrichs
P2
CCC
(52)
Toripalimab
Cervical Cancer
Innolake Biopharm
P2
CCC
(52)
IMMUNOTHERAPIC BIFUNCTIONAL FUSION PROTEIN COMPRISED OF A FULLY HUMAN IGG1 MONOCLONAL ANTIBODY (AVELUMAB) AGAINST HUMAN PROGRAMMED DEATH-LIGAND 1 (PD-L1) FUSED TO THE SOLUBLE EXTRACELLULAR DOMAIN OF TRANSFORMING GROWTH FACTOR-.BETA. (TGF-.BETA.) RECEPTOR II, WHICH ACTS AS A TGF-.BETA. TRAP
Cervical Cancer
National Cancer Institute (NCI)
P2
CCC
(51)
[18f]f-resca-rt4
Cervical Cancer
RenJi Hospital
P2/3
CCC
(50)
[18F]F-RESCA-T4
Cervical Cancer
RenJi Hospital
P2/3
CCC
(50)
[68ga]ga-nota-rt4
Cervical Cancer
RenJi Hospital
P2/3
CCC
(50)
[68ga]ga-nota-t4
Cervical Cancer
RenJi Hospital
P2/3
CCC
(50)
anv419
Cervical Cancer
Vall d'Hebron Institute of Oncology
P2
CCC
(48)
Aprotinin
Cervical Cancer
Sun Yat-sen University
P2
CCC
(48)
Avelumab
Cervical Cancer
Ocellaris Pharma, Inc.
P2
CCC
(48)
Avutometinib
Cervical Cancer
University of Oklahoma
P2
CCC
(48)
Belzutifan
Cervical Cancer
Dana-Farber Cancer Institute
P2
CCC
(48)
Defactinib
Cervical Cancer
University of Oklahoma
P2
CCC
(48)
Efbemalenograstim Alfa
Cervical Cancer
Shandong University
P2
CCC
(48)
her3-dxd
Cervical Cancer
Daiichi Sankyo
P2
CCC
(48)
hlx43
Cervical Cancer
Shanghai Henlius Biotech
P2
CCC
(48)
Pd-L1 T-Hank
Cervical Cancer
ImmunityBio, Inc.
P2
CCC
(48)
Pyruvate
Cervical Cancer
Chang Gung Memorial Hospital
P2
CCC
(48)
Rain-32
Cervical Cancer
Rain Oncology Inc
P2
CCC
(48)
Romiplostim
Cervical Cancer
Peking University People's Hospital
P2
CCC
(48)
Sctil
Cervical Cancer
Peking Union Medical College Hospital
P2
CCC
(48)
Trilaciclib
Cervical Cancer
Sun Yat-sen University
P2
CCC
(48)
Vesanoid
Cervical Cancer
Peking University People's Hospital
P2
CCC
(48)
Showing 26 to 50 of 154 assets
Previous
Page 2 of 7
Next